Case Control Study
Copyright ©The Author(s) 2024.
World J Diabetes. Mar 15, 2024; 15(3): 403-417
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.403
Table 1 Comparison of baseline characteristics among type 2 diabetes mellitus patients stratified by tertiles of the Geriatric Nutritional Risk Index
Characteristics
Total (n = 689)
GNRI tertile 1 (n = 230)
GNRI tertile 2 (n = 230)
GNRI tertile 3 (n = 229)
F/H/χ2
P value
Women [n (%)]295 (42.8)109 (47.4)96 (41.7)90 (39.3)3.0650.080
Age (yr)55.59 ± 10.8858.02 ± 10.4956.00 ± 10.8452.74 ± 10.6928.071< 0.001
Height (cm)166.89 ± 8.24165.25 ± 7.88167.10 ± 8.52168.33 ± 8.0616.410< 0.001
Weight (kg)70.00 (62.00-80.00)62.00 (56.00-69.00)71.00 (64.75-78.85)80.00 (72.75-90.00)16.636< 0.001
Diabetes duration (yr)7.33 ± 6.208.96 ± 6.427.58 ± 6.445.45 ± 5.1538.741< 0.001
BMI (kg/m2)25.39 (23.23-27.78)22.92 (21.31-24.49)25.53 (24.20-26.93)28.28 (26.62-30.47)19.284< 0.001
SBP (mmHg)133.84 ± 15.34132.96 ± 16.80133.89 ± 15.98134.67 ± 12.981.4200.234
DBP (mmHg)81.00 ± 9.8879.44 ± 10.1980.76 ± 9.5082.79 ± 9.7013.343< 0.001
Hypertension [n (%)]333 (48.3)112 (48.7)117 (50.9)104 (45.4)0.4920.483
GNRI (score)105.61 (99.64-112.01)97.09 (93.02-99.66)105.62 (103.73-107.68)114.25 (112.01-119.37)27.818< 0.001
Glucose-lowering therapies [n (%)]
Lifestyle alone121 (17.6)31 (13.5)36 (15.7)54 (23.6)8.0710.004
Insulin treatments248 (36.0)102 (44.3)89 (38.7)57 (24.9)18.817< 0.001
Insulin secretagogues222 (32.2)83 (36.1)78 (33.9)61 (26.6)4.6810.030
Insulin sensitizers79 (11.5)25 (10.9)28 (12.2)26 (11.4)0.0270.870
Metformin322 (46.7)88 (38.3)110 (47.8)124 (54.1)11.622< 0.001
AGIs105 (15.2)23 (10.0)33 (14.3)49 (21.4)11.519< 0.001
DPP-4Is57 (8.3)18 (7.8)23 (10.0)16 (7.0)0.1050.745
SGLT-2Is93 (13.5)28 (12.2)35 (15.2)30 (13.1)0.0850.771
GLP-1RAs41 (6.0)3 (1.3)14 (6.1)24 (10.5)17.240< 0.001
Statins122 (17.7)37 (16.1)45 (19.6)40 (17.5)0.1510.698
Laboratory findings
HbA1c (%)8.99 ± 1.859.50 ± 2.028.92 ± 1.638.53 ± 1.7533.073< 0.001
Albumin (g/L)38.50 (36.20-41.30)35.90 (33.88-37.63)38.60 (37.00-40.60)41.70 (39.45-44.00)17.954< 0.001
Cr (µmol/L)58.51 ± 21.3258.22 ± 25.2257.85 ± 21.5859.46 ± 16.260.3860.535
UA (µmol/L)312.68 ± 99.25279.47 ± 103.09314.02 ± 89.46344.68 ± 94.1953.222< 0.001
TG (mmol/L)1.89 (1.18-3.11)1.46 (0.98-2.33)1.81 (1.15-2.83)2.38 (1.58-3.98)7.626< 0.001
TC (mmol/L)4.41 ± 1.064.29 ± 1.014.33 ± 0.984.62 ± 1.1510.8900.001
HDL-C (mmol/L)1.14 ± 0.271.15 ± 0.281.15 ± 0.251.10 ± 0.273.6790.056
LDL-C (mmol/L)2.81 ± 0.872.80 ± 0.882.80 ± 0.822.84 ± 0.910.3090.578
TBil (µmol/L)11.21 ± 4.7110.25 ± 4.6011.43 ± 4.6811.95 ± 4.7015.213< 0.001
OS (ng/mL)11.85 ± 3.9912.06 ± 4.2611.88 ± 3.8911.60 ± 3.821.5080.220
β-CTX (ng/mL)0.45 ± 0.220.51 ± 0.250.44 ± 0.210.41 ± 0.1925.645< 0.001
TP1NP (ng/mL)40.73 ± 14.5341.00 ± 14.0040.74 ± 14.6640.45 ± 14.980.1650.685
DXA parameters (g/cm2)
LS-BMD0.97 ± 0.160.92 ± 0.140.99 ± 0.170.99 ± 0.1522.118< 0.001
FN-BMD0.77 ± 0.120.73 ± 0.120.79 ± 0.130.81 ± 0.1153.333< 0.001
H-BMD0.91 ± 0.130.85 ± 0.120.91 ± 0.130.95 ± 0.1283.980< 0.001
T-BMD1.10 ± 0.121.07 ± 0.121.10 ± 0.121.12 ± 0.1121.875< 0.001
Body composition
Total body fat (%)31.03 ± 6.5629.03 ± 6.5530.80 ± 5.8333.26 ± 6.6251.017< 0.001
Android/gynoid ratio1.31 ± 0.221.23 ± 0.221.33 ± 0.211.36 ± 0.2049.682< 0.001
Fat mass index (kg/m2)7.53 (6.20-9.09)6.33 (5.08-7.53)7.54 (6.44-8.74)8.91 (7.51-10.75)13.010< 0.001
Lean mass index (kg/m2)16.95 (15.53-18.54)15.66 (14.44-16.83)17.11 (15.92-18.39)18.60 (16.99-19.90)14.055< 0.001
ASMI (kg/m2)7.09 ± 1.176.38 ± 0.917.09 ± 0.977.79 ± 1.1218.066< 0.001